Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2C0Y

THE CRYSTAL STRUCTURE OF A CYS25ALA MUTANT OF HUMAN PROCATHEPSIN S

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsEMBL/DESY, HAMBURG BEAMLINE X13
Synchrotron siteEMBL/DESY, HAMBURG
BeamlineX13
Temperature [K]100
Detector technologyCCD
Collection date2001-06-18
DetectorMARRESEARCH
Spacegroup nameC 2 2 21
Unit cell lengths59.860, 140.540, 78.610
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution19.760 - 2.100
R-factor0.198
Rwork0.198
R-free0.24200
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)1by8
RMSD bond length0.010
RMSD bond angle1.400
Data reduction softwareDENZO
Data scaling softwareSCALEPACK
Phasing softwareAMoRE
Refinement softwareCNS (1.1)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]30.0002.140
High resolution limit [Å]2.1002.100
Rmerge0.0900.470
Number of reflections19350
<I/σ(I)>13.43
Completeness [%]97.988.5
Redundancy6.44.1
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP7.5CRYSTALLISATION WAS PERFORMED BY THE HANGING-DROP VAPOUR DIFFUSION METHOD. EQUAL VOLUMES PROCATHEPSIN S (CYS25ALA) AT 7.0 MG/ML AND WELL SOLUTION WERE COMBINED AND PLACED OVER A WELL CONTAINING 0.1M TRIS/HCL, 0.2M MAGNESIUM ACETATE AND 20% PEG 8000, PH 7.5

226262

PDB entries from 2024-10-16

PDB statisticsPDBj update infoContact PDBjnumon